FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

702799001: Alogliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006162010 Alogliptin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006167016 Alogliptin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alogliptin Is a Oral hypoglycemic false Inferred relationship Some
Alogliptin Is a Dipeptidyl peptidase IV inhibitor true Inferred relationship Some
Alogliptin Has disposition (attribute) Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Some
Alogliptin Is a Chemical categorized functionally false Inferred relationship Some
Alogliptin Is a Enzyme inhibitor false Inferred relationship Some
Alogliptin Is a Piperidine true Inferred relationship Some
Alogliptin Is a Pyrimidine true Inferred relationship Some
Alogliptin Is a Drug or medicament (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Alogliptin benzoate (substance) Is a False Alogliptin Inferred relationship Some
Product containing alogliptin (medicinal product) Has active ingredient True Alogliptin Inferred relationship Some 1
Product containing alogliptin in oral dose form (medicinal product form) Has active ingredient True Alogliptin Inferred relationship Some 1
Alogliptin benzoate (substance) Is modification of (attribute) True Alogliptin Inferred relationship Some
Alogliptin only product Has active ingredient True Alogliptin Inferred relationship Some 1
Alogliptin only product in oral dose form Has active ingredient True Alogliptin Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 25 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 1
Product containing alogliptin and metformin (medicinal product) Has active ingredient True Alogliptin Inferred relationship Some 2
Alogliptin and metformin only product Has active ingredient True Alogliptin Inferred relationship Some 2
Alogliptin- and metformin-containing product in oral dose form Has active ingredient True Alogliptin Inferred relationship Some 2
Alogliptin and metformin only product in oral dose form Has active ingredient True Alogliptin Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Product containing alogliptin and pioglitazone (medicinal product) Has active ingredient True Alogliptin Inferred relationship Some 2
Product containing only alogliptin and pioglitazone (medicinal product) Has active ingredient True Alogliptin Inferred relationship Some 2
Product containing alogliptin and pioglitazone in oral dose form (medicinal product form) Has active ingredient True Alogliptin Inferred relationship Some 2
Alogliptin and pioglitazone only product in oral dose form Has active ingredient True Alogliptin Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Alogliptin Inferred relationship Some 2

This concept is not in any reference sets

Back to Start